The "consideration for the transaction is Rs 338 crore (subject to changes in working capital as on the closing date) which includes transfer of bio-pesticides business of EID Parry together with its stake in the wholly owned subsidiary, Parry America, Inc", the statement said.
The bio-pesticides business is engaged in the manufacture and marketing of neem-based Azadirachtin technical and formulations, plant extract-based bio-stimulants, micronutrients, microbials, and so on, and has brands that are well established in India and globally.
"The transaction is part of the strategic plan of the company to consolidate and focus on its core business in food and nutraceuticals space. Also, it would help the company to keep its gearing at a lower level to handle the sugar cyclical movements", Murugappa Group, Chairman, A Vellayan said.
The bio-pesticides business would gather growth momentum in the hands of Coromandel through their strong position in crop protection business in India, he said.
At 12:36 PM; Coromandel International (up 2.8% at Rs 552) and EID Parry (India) (up 2.2% at Rs 359) were up more than 2% against 0.07% rise in the S&P BSE Sensex.
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Preferential invites to Business Standard events.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in